Literature DB >> 23677496

Baroreflex sensitivity analysis: spontaneous methodology vs. Valsalva's maneuver.

Huan Yang1, Jason R Carter.   

Abstract

INTRODUCTION: Spontaneous analysis techniques and Valsalva's maneuver (VM) are often used as a non-pharamcological approach to assess both sympathetic (sBRS) and cardiovagal (cBRS) baroreflex sensitivity. Despite their wide utilization, no studies have assessed the intra-individual reliability between these analysis techniques. Accordingly, we hypothesized that spontaneous BRS would be positively correlated to VM BRS.
METHODS: Heart rate (HR), blood pressure (BP), and muscle sympathetic nerve activity (MSNA) were measured in 26 healthy subjects (age, 22 ± 1 year; 14 men and 12 women) during 10 min supine rest and 3 VM at 40 mmHg expiratory pressure (15 s, 1 min recoveries). For spontaneous BRS, relations between diastolic BP and MSNA were used to determine sBRS, while relations between systolic BP and R-R interval were used to determine cBRS. During VM, sBRS was the ratio of MSNA and the maximum diastolic BP reduction during early phase II, and cBRS was derived from linear relations between systolic BP and R-R interval during early phase II (i.e., hypotensive stimulus) and phase IV (i.e., hypertensive stimulus).
RESULTS: Spontaneous sBRS was significantly correlated to VM sBRS (r = 0.516, p = 0.036). In contrast, spontaneous cBRS from up-up sequence was not correlated to VM phase IV cBRS (r = 0.274, p = 0.109). Similarly, spontaneous cBRS from down-down sequence was not correlated to VM phase II cBRS (r = 0.199, p = 0.207).
CONCLUSION: In conclusion, our findings demonstrate positive association between spontaneous sBRS and VM sBRS, but there is no correlation between spontaneous and VM cBRS.

Entities:  

Mesh:

Year:  2013        PMID: 23677496     DOI: 10.1007/s10286-013-0195-9

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  26 in total

1.  Baroreflex control of muscle sympathetic nerve activity: a nonpharmacological measure of baroreflex sensitivity.

Authors:  Emma C Hart; Michael J Joyner; B Gunnar Wallin; Tomas Karlsson; Timothy B Curry; Nisha Charkoudian
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-11       Impact factor: 4.733

2.  Valsalva's maneuver revisited: a quantitative method yielding insights into human autonomic control.

Authors:  M L Smith; L A Beightol; J M Fritsch-Yelle; K A Ellenbogen; T R Porter; D L Eckberg
Journal:  Am J Physiol       Date:  1996-09

3.  Age-related changes in baroreflex control of heart rate and sympathetic nerve activity in healthy humans.

Authors:  T Matsukawa; Y Sugiyama; T Mano
Journal:  J Auton Nerv Syst       Date:  1996-09-12

4.  Arterial baroreflex sensitivity assessed from phase IV of the Valsalva maneuver.

Authors:  J Kautzner; J E Hartikainen; A J Camm; M Malik
Journal:  Am J Cardiol       Date:  1996-09-01       Impact factor: 2.778

5.  Long-term effects of carotid sinus denervation on arterial blood pressure in humans.

Authors:  Arthur A J Smit; Henri J L M Timmers; Wouter Wieling; Mariette Wagenaar; Henri A M Marres; Jacques W M Lenders; Gert A van Montfrans; John M Karemaker
Journal:  Circulation       Date:  2002-03-19       Impact factor: 29.690

6.  General characteristics of sympathetic activity in human muscle nerves.

Authors:  W Delius; K E Hagbarth; A Hongell; B G Wallin
Journal:  Acta Physiol Scand       Date:  1972-01

7.  Human muscle nerve sympathetic activity at rest. Relationship to blood pressure and age.

Authors:  G Sundlöf; B G Wallin
Journal:  J Physiol       Date:  1978-01       Impact factor: 5.182

Review 8.  Abnormalities of baroreflex control in heart failure.

Authors:  M D Thames; T Kinugawa; M L Smith; M E Dibner-Dunlap
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

9.  Early depression of the baroreceptor sensitivity during onset of hypertension.

Authors:  E D Moreira; F Ida; V L Oliveira; E M Krieger
Journal:  Hypertension       Date:  1992-02       Impact factor: 10.190

10.  Prolonged activation of the baroreflex produces sustained hypotension.

Authors:  Thomas E Lohmeier; Eric D Irwin; Martin A Rossing; David J Serdar; Robert S Kieval
Journal:  Hypertension       Date:  2004-01-05       Impact factor: 10.190

View more
  6 in total

1.  Meeting international aerobic physical activity guidelines is associated with enhanced cardiovagal baroreflex sensitivity in healthy older adults.

Authors:  Myles W O'Brien; Jarrett A Johns; Tristan W Dorey; Ryan J Frayne; Jonathon R Fowles; Said Mekary; Derek S Kimmerly
Journal:  Clin Auton Res       Date:  2019-10-12       Impact factor: 4.435

2.  Assessment of sympathetic neural activity in chronic insomnia: evidence for elevated cardiovascular risk.

Authors:  Jason R Carter; Daniela Grimaldi; Ida T Fonkoue; Lisa Medalie; Babak Mokhlesi; Eve Van Cauter
Journal:  Sleep       Date:  2018-06-01       Impact factor: 5.849

3.  Sympathetic neural reactivity to the Trier social stress test.

Authors:  Jeremy A Bigalke; Ian M Greenlund; Jennifer R Nicevski; Anne L Tikkanen; Jason R Carter
Journal:  J Physiol       Date:  2022-07-29       Impact factor: 6.228

4.  Sympathetic neural reactivity to mental stress differs in black and non-Hispanic white adults.

Authors:  Ida T Fonkoue; Christopher E Schwartz; Min Wang; Jason R Carter
Journal:  J Appl Physiol (1985)       Date:  2017-09-28

5.  Morning sympathetic activity after evening binge alcohol consumption.

Authors:  Ian M Greenlund; Hannah A Cunningham; Anne L Tikkanen; Jeremy A Bigalke; Carl A Smoot; John J Durocher; Jason R Carter
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-11-13       Impact factor: 4.733

6.  Effectiveness of Different Methods for Baroreflex Sensitivity Assessment in Determining the Severity of Cardiovascular Autonomic Neuropathy in Patients With Parkinson's Disease.

Authors:  Chih-Cheng Huang; Yun-Ru Lai; Chia-Yi Lien; Ben-Chung Cheng; Chia-Te Kung; Yi-Fang Chiang; Cheng-Hsien Lu
Journal:  Front Neurosci       Date:  2022-02-25       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.